Nanologica AB is a nanotechnology and advanced materials company focused on the development and commercialization of nanoporous silica for novel applications in drug delivery, chromatography and therapeutics.

Nanologica’s patented, proprietary technology enables the company to fine-tune the characteristics of porous silica particles and their pores in terms of size, structure and surface chemistry, making them excellent carrier and delivery systems of drugs and effective purification media. Nanologica´s unique technology is based on nanotechnology research at Stockholm University and Uppsala University.